Page last updated: 2024-11-07

penicillamine and Persistent Fetal Circulation Syndrome

penicillamine has been researched along with Persistent Fetal Circulation Syndrome in 2 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Persistent Fetal Circulation Syndrome: A syndrome of persistent PULMONARY HYPERTENSION in the newborn infant (INFANT, NEWBORN) without demonstrable HEART DISEASES. This neonatal condition can be caused by severe pulmonary vasoconstriction (reactive type), hypertrophy of pulmonary arterial muscle (hypertrophic type), or abnormally developed pulmonary arterioles (hypoplastic type). The newborn patient exhibits CYANOSIS and ACIDOSIS due to the persistence of fetal circulatory pattern of right-to-left shunting of blood through a patent ductus arteriosus (DUCTUS ARTERIOSUS, PATENT) and at times a patent foramen ovale (FORAMEN OVALE, PATENT).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brennan, LA1
Steinhorn, RH1
Wedgwood, S1
Mata-Greenwood, E1
Roark, EA1
Russell, JA1
Black, SM1
Lakatos, L1
Oroszlán, G1

Other Studies

2 other studies available for penicillamine and Persistent Fetal Circulation Syndrome

ArticleYear
Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase.
    Circulation research, 2003, Apr-04, Volume: 92, Issue:6

    Topics: Animals; Culture Techniques; Fetus; Humans; Infant, Newborn; Molecular Chaperones; NADPH Oxidases; N

2003
Possible effect of D-penicillamine on the physiologic action of inhaled nitric oxide in neonates.
    The Journal of pediatrics, 1994, Volume: 124, Issue:4

    Topics: Administration, Inhalation; Animals; Animals, Newborn; Drug Interactions; Drug Therapy, Combination;

1994